Pronunciation: (A-lem-TOO-zoo-mab)

A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Alemtuzumab binds to a protein called CD52, which is found on some types of immune cells and cancer cells. This may help the immune system kill cancer cells. Alemtuzumab is a type of monoclonal antibody. Also called Campath.

Source: NCI Dictionary of Cancer Terms

Date last modified: 2014-02-17Alemtuzumab